News

Q2 2025 Earnings Call Transcript August 8, 2025 Operator: Good afternoon, and welcome to the Relmada Therapeutics Second Quarter 2025 Earnings Conference Call. [Operator Instructions] As a reminder, ...
Strategic partnership with Pacific Edge offers Hong Kong clinicians a powerful tool for non-invasive bladder cancer detection ...
A trio of Americans who were diagnosed with and survived bladder cancer have said they caught blood in their pee early, helping doctors assess them.
We at Boulder Medical Center truly applaud Coach Prime for being so transparent about his bladder cancer diagnosis, treatment ...
Bladder cancer is often overlooked, but a recent high-profile diagnosis is helping raise awareness. Football legend and ...
Discover a study exploring muscle-invasive bladder cancer’s risks, diagnosis, and the role of molecular subtyping in ...
Bladder cancer survivors have spoken out on the 'red flag' warning sign and 'most common' symptom they all experienced before ...
After Deion Sanders revealed his recent battle with bladder cancer, experts at the University of Rochester Medical Center are ...
The interstitial cystitis market is limited by a few approved treatments and high unmet need. However, pipeline innovation and rising awareness are expected ...
As July concludes, new treatments offer advances across kidney and bladder cancer, with breakthroughs in personalized vaccines and non-surgical therapies.
Photocure ASA (OSE: PHO) today reported Hexvix®/Cysview® revenues of NOK 135.6 million in the second quarter of 2025 (Q2 2024: NOK ...
A research team led by Professor Seokho Kang of Urology (Professor Seokho Kang, Professor Shim Ji-sung, Professor Roh Tae-il, Professor Yoon Seong-gu) at Korea University Anam Hospital (Director Han ...